ASCO 2026.3.4 Living Guideline: Lorlatinib Takes Priority in First-Line ALK-Positive NSCLC After Landmark Seven-Year CROWN Results
2026 Prix Galien Awards Recognize Major Advances in Cancer Treatment, Screening and Immunotherapy
FASCO 2027: Recognizing Dedication to Oncology
Can the Tumor’s Own B Cells Reveal the Next Immunotherapy Target?
Carla Ferrell and Sista Strut 2026: Breast Cancer Awareness Mission
Adding SPICE to SBRT: Intentional Hotspots Associated with Improved Local Control in Early-Stage NSCLC
Top Gastroesophageal Cancer Updates From ESMO 2026
Re-Irradiation in Pediatric CNS Tumors: Balancing a Second Chance of Cure Against Long-Term Toxicity
The ESMO Breast Cancer 2027 congress, organized by the European Society for Medical Oncology (ESMO), will take place on May 12–14, 2027, at Allianz MiCo in Milan, Italy, with online […]
